1. Home
  2. CHRO vs AUMN Comparison

CHRO vs AUMN Comparison

Compare CHRO & AUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • AUMN
  • Stock Information
  • Founded
  • CHRO 2002
  • AUMN 1996
  • Country
  • CHRO United States
  • AUMN United States
  • Employees
  • CHRO N/A
  • AUMN N/A
  • Industry
  • CHRO
  • AUMN Precious Metals
  • Sector
  • CHRO
  • AUMN Basic Materials
  • Exchange
  • CHRO Nasdaq
  • AUMN Nasdaq
  • Market Cap
  • CHRO 4.2M
  • AUMN 4.1M
  • IPO Year
  • CHRO 2024
  • AUMN 1997
  • Fundamental
  • Price
  • CHRO $0.60
  • AUMN $0.12
  • Analyst Decision
  • CHRO Strong Buy
  • AUMN Strong Buy
  • Analyst Count
  • CHRO 1
  • AUMN 1
  • Target Price
  • CHRO N/A
  • AUMN $1.50
  • AVG Volume (30 Days)
  • CHRO 121.3K
  • AUMN 312.0K
  • Earning Date
  • CHRO 11-13-2024
  • AUMN 11-19-2024
  • Dividend Yield
  • CHRO N/A
  • AUMN N/A
  • EPS Growth
  • CHRO N/A
  • AUMN N/A
  • EPS
  • CHRO N/A
  • AUMN N/A
  • Revenue
  • CHRO N/A
  • AUMN $300,000.00
  • Revenue This Year
  • CHRO N/A
  • AUMN $254.39
  • Revenue Next Year
  • CHRO N/A
  • AUMN $32.53
  • P/E Ratio
  • CHRO N/A
  • AUMN N/A
  • Revenue Growth
  • CHRO N/A
  • AUMN N/A
  • 52 Week Low
  • CHRO $0.45
  • AUMN $0.11
  • 52 Week High
  • CHRO $6.00
  • AUMN $0.79
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 48.49
  • AUMN 16.41
  • Support Level
  • CHRO $0.55
  • AUMN $0.08
  • Resistance Level
  • CHRO $0.71
  • AUMN $0.18
  • Average True Range (ATR)
  • CHRO 0.10
  • AUMN 0.04
  • MACD
  • CHRO -0.00
  • AUMN -0.02
  • Stochastic Oscillator
  • CHRO 23.98
  • AUMN 15.00

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About AUMN Golden Minerals Company

Golden Minerals Co is an exploration stage company engaged in the mining, construction, and exploration of precious metals and mineral properties. It owns and operates Velardena and Chicago precious metals mining properties and associated oxide and sulfide processing plants in the State of Durango, Mexico, the El Quevar exploration property in the province of Salta, Argentina, and a diversified portfolio of precious metals and other mineral exploration properties located in or near historical precious metals producing regions of Mexico. The company's business is structured into two divisions, Mexico operations, and Corporate Exploration and Other.

Share on Social Networks: